Evaluating mycothiolation of xenobiotics
评估外源性物质的霉菌硫醇化
基本信息
- 批准号:10132237
- 负责人:
- 金额:$ 18.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:Actinobacteria classAmidesAnabolismAntibiotic ResistanceAntibioticsBacteriaBindingBiochemicalCatalysisComplexCysteineDefense MechanismsDiseaseDistalDrug Metabolic DetoxicationDrug resistanceDrug usageEnzymesEthionamideExhibitsFutureGenus MycobacteriumGlucosamineGoalsHomeostasisIn VitroKnock-outMapsMetal Binding SiteMolecular WeightMycobacterium InfectionsMycobacterium tuberculosisOxidation-ReductionPathway interactionsPharmaceutical PreparationsPlayPredispositionProcessProdrugsReactionRifampinRoentgen RaysRoleStreptomycinStructureSulfhydryl CompoundsSurfaceSystemTherapeuticTransferaseTuberculosisVancomycinXenobioticsamidasedrug metabolismdrug modificationinsightinterestisoniazidliquid chromatography mass spectrometrymycobacterialnitrocefinpathogenrecruitresistant straintuberculosis drugs
项目摘要
Mycothiol (MSH) is a small molecular weight biomolecule used to modify drugs in the Actinobacteria
phylum. Mycobacterium tuberculosis (Mtb) produces the greatest intracellular concentrations of this
unique thiol-containing biomolecule. Interest regarding MSH biosynthesis in Mtb is due to its
importance in redox homeostasis in the bacterium as well as the role of mycothiol in neutralizing
antibiotics used to treat Mtb infections. The mycothiol S-transferase (MST) enzyme that catalyzes the
conjugation of MSH to a variety of compounds has been identified. Considering the prominent role of
mycothiol in Mtb drug metabolism, a deeper understanding of the structure and function of MST will
lead to a clearer understanding of this important defense mechanism that promotes antibiotic
resistance in Mtb.
真菌硫醇(Mycothiol,MSH)是放线菌中一种用于修饰药物的小分子生物分子
门结核分枝杆菌(Mtb)产生最大的细胞内浓度,
独特的含巯基生物分子。对Mtb中MSH生物合成的兴趣是由于其
细菌中氧化还原稳态的重要性以及真菌硫醇在中和中的作用
用于治疗结核杆菌感染的抗生素。真菌硫醇S-转移酶(MST)催化
已经鉴定了MSH与多种化合物的缀合。考虑到联合国的突出作用,
mycothiol在结核分枝杆菌药物代谢中的作用,深入了解mST的结构和功能,
从而更清楚地了解这种促进抗生素产生重要防御机制
抗结核菌
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donald R Ronning其他文献
Donald R Ronning的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donald R Ronning', 18)}}的其他基金
Mycobacterial trehalose metabolism as drug targets
分枝杆菌海藻糖代谢作为药物靶标
- 批准号:
10207440 - 财政年份:2018
- 资助金额:
$ 18.64万 - 项目类别:
Mycobacterial trehalose metabolism as drug targets
分枝杆菌海藻糖代谢作为药物靶标
- 批准号:
10114418 - 财政年份:2018
- 资助金额:
$ 18.64万 - 项目类别:
Mycobacterial trehalose metabolism as drug targets
分枝杆菌海藻糖代谢作为药物靶标
- 批准号:
10435457 - 财政年份:2018
- 资助金额:
$ 18.64万 - 项目类别:
Understanding trehalose synthesis and utilization in mycobacteria
了解分枝杆菌中海藻糖的合成和利用
- 批准号:
8723058 - 财政年份:2013
- 资助金额:
$ 18.64万 - 项目类别:
Understanding trehalose synthesis and utilization in mycobacteria
了解分枝杆菌中海藻糖的合成和利用
- 批准号:
8883364 - 财政年份:2013
- 资助金额:
$ 18.64万 - 项目类别:
Understanding trehalose synthesis and utilization in mycobacteria
了解分枝杆菌中海藻糖的合成和利用
- 批准号:
8596082 - 财政年份:2013
- 资助金额:
$ 18.64万 - 项目类别:
Understanding the impact of Antigen 85 complex substrate specificity on mycobacte
了解抗原 85 复合物底物特异性对分枝杆菌的影响
- 批准号:
7940613 - 财政年份:2010
- 资助金额:
$ 18.64万 - 项目类别:
相似海外基金
Collaborative Research: NSF-DFG: CAS: Electrochemical Hydrogenation of Amides and Esters
合作研究:NSF-DFG:CAS:酰胺和酯的电化学氢化
- 批准号:
2140205 - 财政年份:2022
- 资助金额:
$ 18.64万 - 项目类别:
Standard Grant
Collaborative Research: NSF-DFG: CAS: Electrochemical Hydrogenation of Amides and Esters
合作研究:NSF-DFG:CAS:酰胺和酯的电化学氢化
- 批准号:
2140196 - 财政年份:2022
- 资助金额:
$ 18.64万 - 项目类别:
Standard Grant
Atroposelective Synthesis of Hindered Amides - Exploration of Synthetic Peptide Catalysts -
受阻酰胺的天体选择性合成-合成肽催化剂的探索-
- 批准号:
504378162 - 财政年份:2022
- 资助金额:
$ 18.64万 - 项目类别:
WBP Fellowship
Development of Peptide Chemical Modification Enabled by N-Halogenation of Amides
酰胺 N-卤化实现的肽化学修饰的发展
- 批准号:
22H02743 - 财政年份:2022
- 资助金额:
$ 18.64万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Modulating Signaling Endocannabinoids and Fatty Acid Amides
调节信号传导内源性大麻素和脂肪酸酰胺
- 批准号:
10532252 - 财政年份:2021
- 资助金额:
$ 18.64万 - 项目类别:
CAREER: SusChEM: Iron Catalysts for the Reduction of Amides
职业:SusChEM:用于还原酰胺的铁催化剂
- 批准号:
2146728 - 财政年份:2021
- 资助金额:
$ 18.64万 - 项目类别:
Continuing Grant
Modulating Signaling Endocannabinoids and Fatty Acid Amides
调节信号传导内源性大麻素和脂肪酸酰胺
- 批准号:
10399712 - 财政年份:2021
- 资助金额:
$ 18.64万 - 项目类别:
Nickel-Catalyzed Alpha-Arylation of Secondary Amides
镍催化仲酰胺的α-芳基化
- 批准号:
558383-2020 - 财政年份:2020
- 资助金额:
$ 18.64万 - 项目类别:
Canadian Graduate Scholarships Foreign Study Supplements
Function of primary fatty acid amides as lipid mediators
伯脂肪酸酰胺作为脂质介质的功能
- 批准号:
20K21285 - 财政年份:2020
- 资助金额:
$ 18.64万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Improving selectivity in Ni-catalyzed activation of amides
提高镍催化酰胺活化的选择性
- 批准号:
518319-2018 - 财政年份:2020
- 资助金额:
$ 18.64万 - 项目类别:
Postgraduate Scholarships - Doctoral